Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

ObjectiveClinical trials have recently shown a connection between nonalcoholic fatty liver disease (NAFLD) and empagliflozin. This paper aimed at comprehensively assessing the effectiveness and security of empagliflozin in NAFLD patients.MethodsPubMed, Embase, Web of Science, Cochrane Library, CNKI,...

Full description

Bibliographic Details
Main Authors: Yuyuan Zhang, Xiaobo Liu, Huazhu Zhang, Xuechang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Endocrinology
Subjects:
NAFLD
empagliflozin
medication
meta-analysis
systematic review
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.836455/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.836455/full

Similar Items